Catalyst Pharmaceuticals Overview
Catalyst Pharmaceuticals Target Price
Analysts' 12-month price predictions for CPRX.
Get informed when a big investor buys or sells
+ FollowShare Price
$31.4
Average Target Price
$31.75
1.1% upside
1.1% upside2 analysts in the last 4 months
High: $32 | Low: $31.5
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-28 | H.C. Wainwright | $31.5 | 0.3% upside |  |
| 2026-05-07 | Stephens | $32 | 1.9% upside | |
| 2025-11-07 | OppenheimerLeland Gershell | $33 | 5.1% upside | |
| 2025-03-03 | Robert W. Baird | $32 | 1.9% upside | |
| 2025-02-04 | Robert W. BairdJoel Beatty | $28 |  10.8% downside | |
| 2025-01-10 | H.C. WainwrightAndrew Fein | $35 | 11.5% upside | |
| 2022-12-21 | Truist Financial | $18 | 42.7% downside | |
| 2022-12-21 | H.C. Wainwright | $24 | 23.6% downside | |
| 2022-12-19 | Piper SandlerJoseph Catanzaro | $20 | 36.3% downside | |
| 2022-08-24 | Roth CapitalScott Henry | $15.5 | 50.6% downside | |
| 2022-08-11 | Truist Financial | $17 | 45.9% downside | |
| 2022-08-11 | H.C. Wainwright | $18 | 42.7% downside | |